Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human SET Polyclonal Antibody

Catalog #:   PHF85501 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q01105
Overview

Catalog No.

PHF85501

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human SET (Lys90-Asn228).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Protein SET, Phosphatase 2A inhibitor I2PP2A, SET, HLA-DR-associated protein II, PHAPII, TAF-I, I-2PP2A, Inhibitor of granzyme A-activated DNase, IGAAD, Template-activating factor I

Purification

Purified by antigen affinity column.

Accession

Q01105

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Various lysates were subjected to SDS PAGE followed by western blot with SET antibody (PHF85501) at 1µg/ml.

    Lane 1: Hela cell lysate
    Lane 2: HepG2 cell lysate
    Lane 3: NIH3T3 cell lysate

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 33 kDa
    Observed MW: 39,41 kDa
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with SET antibody (PHF85501) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 19 kDa
    Observed MW: 19 kDa
References

Stromal Hedgehog Signaling Is Associated with Favorable Outcomes in Pancreatic Cancer., PMID:40508010

The development of functional opsonophagocytic assays to evaluate antibody responses to Klebsiella pneumoniae capsular antigens., PMID:40503906

Nephronophthisis and Retinitis Pigmentosa (Senior-Loken Syndrome) After Living-Donor Kidney Transplantation: Twelve-Year Follow-Up in a Young Woman., PMID:40503542

Effects of Gravitational Acceleration on Physical Fitness, Stress, and Immunity Levels of Prospective Air Force Pilots., PMID:40497823

Selected cytokine and chemokine concentrations in equine autologous conditioned serum are similar under defined and practically relevant storage conditions., PMID:40496923

Viral evolution prediction identifies broadly neutralizing antibodies to existing and prospective SARS-CoV-2 variants., PMID:40494884

Model-informed drug development of Mim8 - a next-generation bispecific antibody for treatment of haemophilia A., PMID:40490062

Predictive power of tertiary lymphoid structure for prognosis and neoadjuvant chemotherapy response in HER2-positive breast cancer., PMID:40489875

A Dynamic Contrast-Enhanced MRI-Based Vision Transformer Model for Distinguishing HER2-Zero, -Low, and -Positive Expression in Breast Cancer and Exploring Model Interpretability., PMID:40488332

From Discovery to Delivery: A Rapid and Targeted Proteomics Workflow for Monitoring Chinese Hamster Ovary Biomanufacturing., PMID:40480342

T cell memory alters pulmonary inflammatory responses to cecal ligation and puncture., PMID:40475466

Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study., PMID:40473445

Prevalence of Toxocara infection and associated risk factors: a cross-sectional study in Zhejiang, China., PMID:40468417

An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilance., PMID:40467118

The current state-of-the-art approaches and emerging opportunities for hydrophobic interaction chromatography for the characterization of intact proteins and biotherapeutics., PMID:40460523

No additional benefit with detoxification strategies: A real world experience in 200 patients with chronic migraine and either simple or complex MOH treated with CGRP monoclonal antibodies., PMID:40457764

Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial., PMID:40456235

Cutaneous adverse effects of combination epidermal growth factor receptor inhibitor and immune checkpoint inhibitor cancer therapy., PMID:40455297

Seroprevalence of brucellosis in humans with non-specific clinical symptoms in Punjab, India., PMID:40453952

Serological and molecular investigation of Neospora caninum in cattle in Al-Diwaniyah province, Iraq., PMID:40453836

Prevalence of epsilon toxin-producing Clostridium perfringens isolates among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Iran., PMID:40450217

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study., PMID:40449498

Focal High-Grade Areas with a Tumor-in-Tumor Pattern: Another Feature of Pediatric DICER1-Associated Thyroid Carcinoma?, PMID:40448797

Hyperimmune serum containing Histophilus somni rHsp60, rOMP40 and Actinobacillus pleuropneumoniae LPS antibodies as supplementary treatment for calf respiratory diseases., PMID:40447709

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia., PMID:40447498

A validation workflow for novel oligonucleotide sequences to expand the multiplexing capacity of the CODEX platform., PMID:40447231

Mechanistic insights into the stimulation of the histone H3K9 methyltransferase Clr4 by proximal H3K14 ubiquitination., PMID:40446033

Comparison of sequence- and structure-based antibody clustering approaches on simulated repertoire sequencing data., PMID:40445971

Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors., PMID:40442785

High-Efficient and Controllable Purification of Protein by Cyclic Injection in an Orthogonal Micro-Free-Flow Electrophoresis., PMID:40442025

Serum antineuronal antibodies in patients with post-COVID-19 condition - association to intensive care., PMID:40441540

Co-inhibition of Notch1 and ChK1 triggers genomic instability and melanoma cell death increasing the lifespan of mice bearing melanoma brain metastasis., PMID:40437523

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study., PMID:40436854

CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures., PMID:40435316

GPT-driven generation and biological activity evaluation of novel mRNA trinucleotide Cap1 analogs for mRNA vaccine or immunotherapy., PMID:40433678

Serological Correlate of Protection Established by Neutralizing Antibodies Differs Among Dialysis Patients with SARS-CoV-2 Variants of Concern., PMID:40432127

The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial., PMID:40432079

Efficient Design of Affilin® Protein Binders for HER3., PMID:40429825

Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer., PMID:40427538

Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus., PMID:40426240

Reliable protein-protein docking with AlphaFold, Rosetta, and replica exchange., PMID:40424178

ADCNet: a unified framework for predicting the activity of antibody-drug conjugates., PMID:40421657

A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines., PMID:40420402

Predicting the risk of ibrutinib in combination with R-ICE in patients with relapsed or refractory DLBCL using explainable machine learning algorithms., PMID:40418267

Adjusted Global Antiphospholipid Syndrome Score Is Associated with End-Stage Kidney Disease in Patients with ANCA-Associated Vasculitis: A Single-Centre Pilot Study., PMID:40414825

Deep learning-based histopathologic segmentation of peritubular capillaries in kidney transplant biopsies., PMID:40413895

Influence of Disease Type and Activity on Adalimumab Exposure in Children with Inflammatory Rheumatic Diseases., PMID:40410850

Prevalence-based screening by anti-HCV reflex HCV antigen test and accessible post-screening care towards elimination of hepatitis C in rural villages., PMID:40410707

177Lu-Anti-CD25 Antibody for Interleukin-2 Receptor-α-Targeted Radioimmunotherapy of SUDHL1 Lymphomas in Mice., PMID:40408541

Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaoundé-Cameroon., PMID:40408399

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human SET Polyclonal Antibody [PHF85501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only